SEC Filing Summary: ChromaDex Corp. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on May 7, 2013, by ChromaDex Corp. (Note: The input metadata references "Niagen Bioscience, Inc.", but the filing text identifies the registrant as ChromaDex Corp.). The report discloses the entry into a material definitive agreement regarding the company's corporate headquarters lease.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on lease terms:
- Existing Premises: Approximately 12,686 square feet at 10005 Muirlands Blvd., Irvine, CA.
- New Premises: Addition of 2,126 square feet (Suite L) at the same location.
- Total Leased Space: Approximately 14,812 square feet.
- Lease Term Extension: Extended through September 30, 2019.
- Base Rent (July 1, 2013 – April 30, 2014): Annualized range of $7,850.36 to $15,996.96.
- Base Rent (May 1, 2014 – September 30, 2019): Annualized range of $16,737.56 to $20,440.56.
Material Changes
The primary material change is the amendment of the Standard Industrial/Commercial Multi-Tenant Lease dated December 19, 2006. Key changes include:
- Expansion of leased square footage by 2,126 sq. ft.
- Extension of the lease term to September 30, 2019.
- Implementation of a stepped rent structure with increased annualized base rent starting May 1, 2014.
- Granting of a right of first refusal for additional office space (Suites M, N, and O).
Outlook, Risks, and Unusual Items
Management Commentary: The company is expanding its headquarters footprint to accommodate growth. Tenant improvements for the new space will be constructed at ChromaDex's cost and expense, subject to the Lessor's reasonable approval.
Risks/Contingencies: The filing notes that the description of the Lease Amendment is qualified in its entirety by reference to the full agreement filed as Exhibit 10.1. There are no unusual items or specific risk factors disclosed beyond the standard obligations of the lease.
Investor Verification Checklist
- Verify the total annualized rent obligation for the full lease term (2013–2019) by reviewing Exhibit 10.1.
- Confirm the estimated cost of tenant improvements required for the new 2,126 sq. ft. space.
- Assess the impact of the extended lease term on the company's long-term fixed operating costs.
- Review the specific terms of the "right of first refusal" for Suites M, N, and O to understand future expansion flexibility.